Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Mitogen-activated protein kinases in heart development and diseases Wang YCirculation 2007[Sep]; 116 (12): 1413-23Mitogen-activated protein (MAP) kinases belong to a highly conserved family of Ser-Thr protein kinases in the human kinome and have diverse roles in broad physiological functions. The 4 best-characterized MAP kinase pathways, ERK1/2, JNK, p38, and ERK5, have been implicated in different aspects of cardiac regulation, from development to pathological remodeling. Recent advancements in the development of kinase-specific inhibitors and genetically engineered animal models have revealed significant new insights about MAP kinase pathways in the heart. However, this explosive body of new information also has yielded many controversies about the functional role of specific MAP kinases as either detrimental promoters or critical protectors of the heart during cardiac pathological processes. These uncertainties have raised questions on whether/how MAP kinases can be targeted to develop effective therapies against heart diseases. In this review, recent studies examining the role of MAP kinase subfamilies in cardiac development, hypertrophy, and survival are summarized.|Animals[MESH]|Animals, Genetically Modified[MESH]|Clinical Trials as Topic[MESH]|Cricetinae[MESH]|Drug Evaluation, Preclinical[MESH]|Fetal Heart/enzymology[MESH]|Heart Defects, Congenital/enzymology[MESH]|Heart Diseases/drug therapy/*enzymology[MESH]|Humans[MESH]|MAP Kinase Signaling System/physiology[MESH]|Mice[MESH]|Mitogen-Activated Protein Kinases/antagonists & inhibitors/genetics/*physiology[MESH]|Myocardium/*enzymology[MESH]|Protein Kinase Inhibitors/pharmacology/therapeutic use[MESH] |